Support for your GLP-1 journey While digestive side effects can be uncomfortable at-first, they are usually temporary and manageable
discontinuation is considered when they cluster with severe nausea, vomiting, or signs of gastroparesis progression What is actually happening in the stomach Semaglutide slows gastric emptying through its action on GLP-1 receptors in the enteric nervous system and via central vagal pathways
Shotsy organizes your doses, side effects, and weight into a clear timeline and lets you export it to a PDF to share with your doctor
Lazzer S, Bedogni G, Agosti F, De Col A, Mornati D, Sartorio A
Active, not recruiting Atherosclerotic Cardiovascular Disease Drug: Obicetrapib Drug: Placebo Continuation Protocol for Obstructive Sleep Apnea (OSA) The combination drug composed of aroxybutynin and atomoxetine, designated AD109, is being developed by Apnimed for the treatment of obstructive sleep